| Literature DB >> 23356794 |
Santiago Comba1, Simón Menendez-Bravo, Ana Arabolaza, Hugo Gramajo.
Abstract
BACKGROUND: Phosphatidic acid phosphatase (PAP, EC 3.1.3.4) catalyzes the dephosphorylation of phosphatidate yielding diacylglycerol (DAG), the lipid precursor for triacylglycerol (TAG) biosynthesis. Despite the importance of PAP activity in TAG producing bacteria, studies to establish its role in lipid metabolism have been so far restricted only to eukaryotes. Considering the increasing interest of bacterial TAG as a potential source of raw material for biofuel production, we have focused our studies on the identification and physiological characterization of the putative PAP present in the TAG producing bacterium Streptomyces coelicolor.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23356794 PMCID: PMC3599759 DOI: 10.1186/1475-2859-12-9
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1Biosynthesis of membrane glycerophospholipids and triacylglycerols in . PA is the metabolic branch point dividing glycerophospholipid and triacylglycerol biosynthesis. (1) G3P:acyltransferase. (2) Lisophosphatidic acid acyltransferase. (3) Phosphatidate cytidylyltransferase. (4) Phosphatidyltransferase. (5) Phosphatic acid phosphatase. (6) Diacylglycerol:acyltransferase.
Figure 2Bioinformatic analysis of PAPs. (A) Sequence alignment of scoLPPs PAP2 domains. The key residues for this catalytic activity are underlined. (B) Phylogenetic tree of LPP enzymes from different organisms. Bootstrap values are shown along the branches. (C) Transmembrane topology prediction of scoLPPs. Numbers represent amino acid position of start and end of the respective transmembrane helix. Location of the catalytic domains is represented with black stars. Sequence accession numbers: atLPP_alfa1 [EMBL:Q9ZU49], atLPP_alfa2 [EMBL:Q9XI60], atLPP_alfa3 [EMBL:Q8LFD1], atLPP_epsilon1 [EMBL:F4J220], atLPP_epsilon2 [EMBL:Q6NQL6], atLPP_gamma [EMBL:Q6NLA5], scLPP1p [EMBL:Q04396], scDPP1p [EMBL:Q05521], hsLPP1 [EMBL:O14494], hsLPP2 [EMBL:O43688], mmLPP1 [EMBL:Q61469], mmLPP2 [EMBL:Q9DAX2], scoLPPα [EMBL:Q9K3P6], scoLPPβ [EMBL:Q9EWX3], scoLPPγ [EMBL:O86624], synLPP [EMBL:Q55398].
Figure 3Heterologous expression of scoLPPs in and analysis of their lipid profile. (A) Immunoblot analysis of E. coli soluble fractions with anti-His antibodies. (B) Total lipid extracts from [14C] acetic acid-labelled cultures of the indicated E. coli strains were analyzed on silica gel TLC plates and developed in hexane:diethylether:acetic acid (70:30:1, v/v/v). FA: Fatty Acids. DAG: Diacylglycerol. PL: Phospholipid. (+): Inducer added. (−): No inducer.
Phosphatidic acid phosphatase activity in membranes of expressing scoLPPs
| C41(DE3)/pBAD33 | 0.9 ± 0.2 |
| C41(DE3)/pBAD-LPPα | 2.51 ± 0.06 |
| C41(DE3)/pBAD-LPPβ | 4.5 ± 0.1 |
| C41(DE3)/pBAD-LPPγ | 1.02 ± 0.08 |
aValues represent the mean S.D. of triplicate determinations.
Figure 4Complementation of the temperature sensitive phenotype of yeast knockout strain by expressing scoLPPs. W3031A: wild type strain; GHY58 (lpp1dpp1pah1): triple knockout mutant strain; GHY58/p425GPD, GHY58/scoLppγ, GHY58/scoLppβ, GHY58/scoLppα: triple knockout strain transformed with p425GPD empty vector and with p425GPD expressing scoLppγ, scoLppβ or scoLppα. 10 μl of each dilution were spotted on the plates, and followed by incubation at 30 and 37°C for two days.
Figure 5Analysis of the role of Lppα and Lppβ in TAG accumulation. (A) Total lipid extracts from cultures of the indicated S. coelicolor strains grown on SMM medium during 20, 24 and 30 h, were analyzed on silica gel TLC plates and developed in hexane:diethylether:acetic acid (70:30:1, v/v/v). (B) Quantification of TAG content of S. coelicolor strains overexpressing the indicated scoLPPs. Stars mean significant differences respect to empty plasmid control strain (p < 0.05). TAG: Triacylglycerol. FA: Fatty Acid. DAG: Diacylglycerol. PL: Phospholipid.
Strains and plasmids
| | | |
| | | |
| M145 | Parental strain, SCP1- SCP2- | [ |
| SC_1102 | SCO1102:: | This study |
| SC_1753 | SCO1753:: | This study |
| SC_1153 | SCO1102:: | This study |
| SC_285 | M145 | This study |
| SC_Lppα | M145 | This study |
| SC_Lppβ | M145 | This study |
| SC_P1102 | SC_1153 | This study |
| SC_P1753 | SC_1153 | This study |
| | | |
| DH5α | [ | |
| BL21 (DE3) | Novagen | |
| C41 (DE3) | Lucigen | |
| ET 12567 | [ | |
| | | |
| W303-1A | [ | |
| GHY58 | [ | |
| | | |
| pET28a | Vector for expression of N terminal His-tagged proteins under the strong T7 promoter; KmR | Novagen |
| pBAD33 | Vector for recombinant protein expression under the control of the | [ |
| pCR®-BluntII-TOPO | Vector used for cloning of blunt PCR products; KmR | Invitrogen |
| pUZ8002 | RK2 derivative with defective | [ |
| pKOS111-47 | RK2 derivative with defective | B. Julien (Personal communication) |
| pQM5066 | Plasmid carrying a copy of | P. Dyson, (Personal communication) |
| pRT802 | Intregrative vector based on ΦBT1 phage integrase; KmR | [ |
| p425GPD | Multicopy Yeast/ | [ |
| pTR285 | pRT802 derivative carrying the | [ |
| pBAD0958 | pBAD33 carrying the SCO0958His gene under the control of | [ |
| pBAD-LPPα | pBAD33 carrying the SCO1102His gene under the control of | This study |
| pBAD-LPPβ | pBAD33 carrying the SCO1753His gene under the control of | This study |
| pBAD-LPPγ | pBAD33 carrying the SCO6355His gene under the control of | This study |
| p425-LPPα | p425-GPD carrying the SCO1102His gene under the control of GPD promoter; ApR, LEU2 | This study |
| p425-LPPβ | p425-GPD carrying the SCO1753His gene under the control of GPD promoter; ApR, LEU2 | This study |
| p425-LPPγ | p425-GPD carrying the SCO6355His gene under the control of GPD promoter; ApR, LEU2 | This study |
| p28-LPPα | pET28 carrying the SCO1102His gene under the control of T7 promoter; KmR | This study |
| p28-LPPβ | pET28 carrying the SCO1753His gene under the control of T7 promoter; KmR | This study |
| p285-LPPα | pTR285 carrying the SCO1102His gene under the control of | This study |
| p285-LPPβ | pTR285 carrying the SCO1753His gene under the control of | This study |
| pRT802-LPPα | pRT802 carrying the SCO1102His gene under the control of its own promoter; KmR | This study |
| pRT802-LPPβ | pRT802 carrying the SCO1753His gene under the control of its own promoter; KmR | This study |
Figure 6Reconstitution of TAG biosynthesis pathway in . Total lipid extracts from [14C] acetic acid-labeled cultures of the indicated E. coli strains were analyzed on silica gel TLC plates and developed in hexane:diethylether:acetic acid (70:30:1, v/v/v). TAG: Triacylglycerol. FA: Fatty Acid. DAG: Diacylglycerol. PL: Phospholipid.
Primers
| EZR1 | ATGCGCTCCATCAAGAAGAG | [ |
| EZL2 | TCCAGCTCGACCAGGATG | [ |
| SCO1102_F | C | This study |
| SCO1102_R | TGGCC | This study |
| SCO1753_F | CGAT | This study |
| SCO1753_R | CCCC | This study |
| SCO6355_F | GGGT | This study |
| SCO6355_R | GT | This study |
| P1102_F | This study | |
| P1102_R | This study | |
| P1753_F | This study | |
| P1753_R | This study |
Restriction sites are shown underlined.